Healthy Extracts (HYEX) AI Stock Analysis

• Market Cap: $6.12M
• Dividend Yield: N/A
• Average Volume (3M): 800.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.90
• Revenue Growth: 25.24%
• EPS Growth: 66.44%
• Country: US
• Employees: 2
• Sector: Healthcare
• Sector Strength: 44
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.13
• Shares Outstanding: 3,136,906
• 10 Day Avg. Volume: 1,582
• 30 Day Avg. Volume: 800
• PEG Ratio: 0.25
• Price to Book (P/B): 7.29
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -39.95
• Enterprise Value/Market Cap: 0.96
• Enterprise Value/Revenue: 0.48
• Enterprise Value/Gross Profit: 3.05
• Enterprise Value/Ebitda: -2.00
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: ―

Healthy Extracts' stock reflects a moderate score driven primarily by its financial performance and technical analysis. While the company shows revenue growth potential, persistent profitability challenges and high leverage are significant risks. The stock's technical indicators suggest a bullish trend, but overbought conditions warrant caution. The negative P/E ratio and lack of dividends further impact the overall score.

Healthy Extracts Business Overview & Revenue Model

Company Description

Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.

How the Company Makes Money

Healthy Extracts makes money primarily through the sale of its nutraceutical products. The company generates revenue by selling directly to consumers through its e-commerce platform and by distributing its products through various retail and online channels. Key revenue streams include the sales of their branded supplements and custom formulations. The company also benefits from strategic partnerships with other health and wellness brands, which help expand its distribution network and increase product visibility. Additionally, Healthy Extracts may engage in licensing agreements for their proprietary formulations, providing another revenue source.

Healthy Extracts Financial Statement Overview

Summary

Healthy Extracts shows potential in revenue growth, yet struggles with profitability and financial leverage. The improvement in cash flow is promising, but the persistent negative earnings and high leverage present ongoing risks.

Income Statement

Healthy Extracts has shown a significant improvement in revenue over the years, with a notable revenue growth from 2023 to 2024. However, the company still struggles with profitability, reporting a negative net income and EBIT consistently, indicating ongoing operational challenges. While gross profit margins are positive, the persistent negative net profit margins highlight the difficulty in converting sales to profit.

Balance Sheet

The company's balance sheet indicates a high level of debt relative to equity, with a concerning debt-to-equity ratio that reflects financial leverage risks. Despite this, the equity ratio is positive, suggesting some degree of financial stability. Nonetheless, the declining stockholders' equity over recent years poses a risk to financial health.

Cash Flow

Cash flow statements reveal an improvement in operating cash flow with a positive free cash flow in the latest year, marking a positive shift from previous periods of negative cash flow. However, the cash flow to net income ratio remains unfavorable due to the negative net income, indicating challenges in translating operational success to bottom-line profitability.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
3.36M	3.11M	2.49M	2.25M	1.47M	1.28M
	Gross Profit
1.93M	1.91M	1.62M	1.37M	695.08K	-578.44K
	EBIT
-229.48K	-183.15K	-2.24M	-904.75K	-1.89M	-2.05M
	EBITDA
-54.91K	-183.15K	-2.24M	-910.71K	-1.89M	-2.49M
	Net Income Common Stockholders
-377.82K	-840.67K	-2.47M	-989.96K	-2.04M	-2.65M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
118.80K	112.02K	19.44K	65.65K	222.10K	59.20K
	Total Assets
2.41M	2.38M	2.64M	2.78M	3.03M	3.12M
	Total Debt
1.08M	941.90K	1.13M	593.52K	342.62K	177.62K
	Net Debt
957.79K	829.88K	1.11M	527.87K	120.52K	118.42K
	Total Liabilities
2.35M	1.97M	1.68M	902.79K	558.84K	261.61K
	Stockholders Equity
60.51K	410.38K	954.59K	1.88M	2.47M	2.85M
Cash Flow		Free Cash Flow
323.26K	281.97K	-415.75K	-342.95K	-997.30K	-3.49M
	Operating Cash Flow
323.26K	281.97K	-415.75K	-334.96K	-901.30K	-3.48M
	Investing Cash Flow
0.00	0.00	0.00	-7.99K	-96.00K	-425.88K
	Financing Cash Flow
-291.78K	-189.39K	369.54K	239.52K	1.16M	3.83M

Healthy Extracts Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYEX, the sentiment is Negative. The current price of 1.95 is below the 20-day moving average (MA) of 2.20, below the 50-day MA of 2.72, and below the 200-day MA of 2.48, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 42.04 is Neutral, neither overbought nor oversold. The STOCH value of 38.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HYEX.

Healthy Extracts Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HYEX	56 Neutral	$6.12M	―	-356.18%	―	25.24%	66.44%
Sector *	54 Neutral	$5.38B	3.40	-45.06%	3.28%	16.75%	-0.02%
TLPH	41 Neutral	$10.46M	―	-106.83%	―	-100.00%	65.76%
CPHI	39 Underperform	$5.23M	―	-59.14%	―	-33.10%	71.37%
SISI		$9.14M	―	-58.27%	―	―	―
COSM	49 Neutral	$14.30M	―	-58.30%	―	―	―
FLGC	46 Neutral	$15.59M	―	-336.65%	―	-28.78%	86.97%